IotaMotion, Inc—a medical device company focused on developing advanced robotic systems for cochlear implant surgery—announced the formation of its Scientific Advisory Board (SAB) with two key appointments: Craig A. Buchman, MD, and J. Thomas Roland Jr, MD two world-renowned cochlear implant surgeons, who join Dr Bruce Gantz (chair and head of the Department of Otolaryngology—Head and Neck Surgery at the University of Iowa) who serves as an esteemed advisor to the company.
The SAB will work closely with the iotaMotion management team as it advances its product pipeline. The company is developing technology that is designed to enable surgeons to achieve more precise, individualized solutions for patients experiencing various types of hearing loss. The company’s first product, iotaSOFT™, is a robotic-assisted insertion device that is designed to allow surgeons to advance cochlear implant electrodes with the precision of robotics. According to the company, controlled insertion may lead to less surgical variability in outcomes and results, while helping to protect existing structures from the damage of manual insertion.
“We are thrilled to have attracted the world’s leading experts in cochlear implants as we develop our suite of robotic-assisted systems that have the potential to significantly advance the state of technology for cochlear implant surgery,” said Chris Kaufmann, MD, co-founder of iotaMotion. “Importantly, the formation of our SAB serves as an endorsement for scientific and clinical enthusiasm for the technologies under development. We look forward to working closely with Drs Buchman and Roland.”